SCHEMBL6653402

SCHEMBL6653402

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c(C(=O)OC4CCCCCCC4)c(C)c4ccccc4c3O2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 3/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ADORA2B P29275 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
CACNA1B Q00975 1/20 0.34
TSHR P16473 3/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650817 0.92 KMT2A (0.41) L3MBTL1TP53MEN1KMT2AADORA2B
SCHEMBL17929237 0.87 TSHR (0.36) L3MBTL1TP53MEN1KMT2AADORA2B
SCHEMBL6650625 0.86 MEN1 (0.35) L3MBTL1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8978512 0.85 ATM (0.41) L3MBTL1TP53MEN1KMT2ATDP1
SCHEMBL17929228 0.85 TP53 (0.33) L3MBTL1TP53KMT2AADORA2BTDP1
SCHEMBL6653783 0.85 ALDH1A1 (0.40) L3MBTL1TP53MEN1KMT2ASMN1; SMN2
SCHEMBL10102254 0.83 ATM (0.39) L3MBTL1TP53MEN1KMT2ATDP1
SCHEMBL6651346 0.81 L3MBTL1 (0.36) L3MBTL1TP53KMT2AADORA2BTDP1
SCHEMBL17929226 0.81 ATM (0.38) L3MBTL1TP53MEN1KMT2ATDP1
SCHEMBL6653085 0.79 KMT2A (0.39) L3MBTL1TP53MEN1KMT2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1248778-B1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG IND OHIO INC (US) 2004-06-16 EP claimed
US-6340766-B1 PHOTOCHROMIC DYES ON SUBSTRATES LIKE GLASS WITH PROTECTIVE COATINGS TRANSITION OPTICAL, INC. 2002-01-22 US claimed
US-20020007078-A1 Novel substituted naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2002-01-17 US claimed
EP-1248778-B1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG IND OHIO INC (US) 2004-06-16 EP disclosed
US-6340766-B1 PHOTOCHROMIC DYES ON SUBSTRATES LIKE GLASS WITH PROTECTIVE COATINGS TRANSITION OPTICAL, INC. 2002-01-22 US disclosed
US-20020007078-A1 Novel substituted naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007078-A1 Novel substituted naphthopyrans CRYZ, NR2E3, UACA L3MBTL1 4785/4885TP53 2481/4885MEN1 4666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.